Stay updated on Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.

Latest updates to the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Study Record History now shows a new revision entry, Revision: v3.7.0, while the previous Revision: v3.6.6 is removed from the history. This indicates a system release update to the record page rather than a change to the study data or core content.SummaryDifference0.1%

- Check55 days agoChange DetectedVersion v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed from the log. This updates the version history to reflect the latest revision of the study record.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history page now shows Revision: v3.6.5 instead of v3.6.4, indicating a new interface release; this is a system-level update with no changes to the study data.SummaryDifference0.1%

- Check91 days agoChange DetectedThe record history now reflects a new site revision, v3.6.4, replacing the previous v3.6.3.SummaryDifference0.1%

Stay in the know with updates to Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan, Azacitidine & Venetoclax in AML Clinical Trial page.